Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
Validation of a Personalised Medicine Tool for Multiple Myeloma That Predicts Treatment Effectiveness in Patients
ClinicalTrials.gov study NCT03409692. IPD Sharing: NO. Countries: 1. Publications: 0.
BCMA-CAR-T in Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT03664661. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Impact of a Health Technology Intervention on Patient Activation in Multiple Myeloma
ClinicalTrials.gov study NCT05673083. IPD Sharing: NO. Countries: 1. Publications: 0.
A Feasibility and Safety Study of Dual Specificity CD38 and BCMA CAR-T Cell Immunotherapy for Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT03767751. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Etiology of Multiple Myeloma: A Case-Control Study
ClinicalTrials.gov study NCT00505999. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Novel Combination of Belantamab Mafodotin and Elotuzumab to Enhance Therapeutic Efficacy in Multiple Myeloma
ClinicalTrials.gov study NCT05002816. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
LCAR-M61S and LCAR-M61D in Treatment of Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT06472479. IPD Sharing: NO. Countries: 1. Publications: 0.
Arsenic Trioxide and Ascorbic Acid Combined With Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia
ClinicalTrials.gov study NCT00258245. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety Study of Lenalidomide/Dexamethasone to Treat Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT02692339. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clarithromycin Plus CTd Regimen for Patients With Newly Diagnosed Multiple Myeloma
ClinicalTrials.gov study NCT02248428. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Anti-BCMA Chimeric Antigen Receptor T Cells for Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT05577000. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase 1 Dose-Escalation Study in Advanced Solid Tumors, Lymphomas or Multiple Myeloma
ClinicalTrials.gov study NCT00725634. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Multiple Myeloma and Exercise
ClinicalTrials.gov study NCT01809717. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase I Clinical Trial of Y150 in the Treatment of Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT05011097. IPD Sharing: NO. Countries: 1. Publications: 0.
A Real World Study of Elranatamab in Patients With RR Multiple Myeloma in Taiwan
ClinicalTrials.gov study NCT07391761. IPD Sharing: NO. Countries: 1. Publications: 0.
Assessment of Bortezomib (Alvocade ®) Efficacy and Safety in Newly Diagnosed Multiple Myeloma Patients
ClinicalTrials.gov study NCT04348006. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Real World Study of Equecabtagene Autoleucel in Subjects With Relapsed and Refractory Multiple Myeloma.
ClinicalTrials.gov study NCT06369935. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study Assessing the Health-Related Quality of Life (HRQoL) in Participants With Relapsed and/or Refractory Multiple Myeloma (RRMM) With Triple Class Exposure
ClinicalTrials.gov study NCT05217082. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Brostallicin in Treating Patients With Recurrent or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT00060203. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Treatment of High-risk Newly Diagnosed Multiple Myeloma With Minimal Residual Disease Detection
ClinicalTrials.gov study NCT06409702. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.